Legacy Air Rocky Mountain
Legacy Air Rocky Mountain is a pioneering biotech company in Denver, specializing in the development of nasal-spray, self-adjuvanting vaccines for viral respiratory diseases. Their Delta NS1 technology platform is the foundation for the DeltaFLU Universal Influenza Vaccine, currently in Phase 2 clinical development to provide broad protection against all strains of influenza.
With a focus on innovation and public health, Legacy Air Rocky Mountain is also working on the Delta-19 Covid-19 Universal Influenza combination vaccine to combat the dual threat of SARS-CoV-2 and influenza pandemics. Their cutting-edge approach aims to address the evolving challenges of infectious diseases with advanced vaccine solutions.
Generated from their website's infomation
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.




